JoNel Aleccia, Kaiser Health News
Patients fend for themselves to access highly touted COVID antibody treatments
January 20, 2021
Scores of high-risk COVID patients who are eligible remain unaware or have not been offered the option.
Signs of an ‘October vaccine surprise’ alarm career scientists
September 22, 2020
If the executive branch were to overrule the FDA’s scientific judgment, a vaccine of limited efficacy and, worse, unknown side effects could be rushed to market.